Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Rev Neurol (Paris) ; 168(6-7): 533-7, 2012 Jun.
Artigo em Francês | MEDLINE | ID: mdl-22627088

RESUMO

INTRODUCTION: Cerebral vasculitis is a rare and severe condition, posing problems for diagnosis and treatment. Toxocara canis cerebral vasculitis is exceptionally rare, with only 4 cases having been reported. We report an additional case revealed by iterative strokes. OBSERVATION: A 49-years-old Laotian man presented with right ACA infarction associated with contrast enhancement of cerebrospinal fluid, and multiple segmental stenoses in small and medium caliber encephalic arteries, in a context of hypereosinophilia and chronic headaches. Laboratory tests showed lymphocytic meningitis and T. canis antibody IgE in the blood and CSF. The diagnosis of T. canis cerebral vasculitis was retained. During follow-up, the patient presented again with left pontine hemorrhagic stroke. Conventional cerebral angiography confirmed progression of vasculitis despite treatment. CONCLUSION: This case-report illustrates the diagnostic and therapeutic difficulties associated with vasculitis.


Assuntos
Acidente Vascular Cerebral/etiologia , Toxocara canis , Toxocaríase/complicações , Vasculite do Sistema Nervoso Central/etiologia , Albendazol/uso terapêutico , Animais , Anti-Helmínticos/uso terapêutico , Angiografia Cerebral , Hemorragia Cerebral/etiologia , Hemorragia Cerebral/parasitologia , Cefaleia/etiologia , Humanos , Imunoglobulina E/sangue , Imunoglobulina E/líquido cefalorraquidiano , Imunoglobulina E/imunologia , Infarto da Artéria Cerebral Anterior/tratamento farmacológico , Infarto da Artéria Cerebral Anterior/etiologia , Infarto da Artéria Cerebral Anterior/parasitologia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Ponte/patologia , Acidente Vascular Cerebral/parasitologia , Toxocaríase/tratamento farmacológico , Toxocaríase/parasitologia , Vasculite do Sistema Nervoso Central/tratamento farmacológico , Vasculite do Sistema Nervoso Central/parasitologia
2.
Rev Neurol (Paris) ; 162(8-9): 876-8, 2006 Sep.
Artigo em Francês | MEDLINE | ID: mdl-17028553

RESUMO

With steroid therapy, it is commonly considered that prognosis is good in giant cell arteritis. However serious or even fatal complications may occur. Here we report the case of a patient who developed fatal giant cell arteritis with severe stenosis of both vertebral arteries and right carotid siphon. Several similar cases have been reported in the literature. Initially diagnosis may be difficult because neurological manifestations are intermittent and classical signs of giant cell arteritis may be lacking. In such condition the reason of poor outcome is unknown and therapy remains empiric.


Assuntos
Arteriopatias Oclusivas/complicações , Arterite de Células Gigantes/complicações , Coluna Vertebral/irrigação sanguínea , Idoso , Arteriopatias Oclusivas/patologia , Evolução Fatal , Lateralidade Funcional , Arterite de Células Gigantes/patologia , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade
3.
Rev Neurol (Paris) ; 162(1): 82-8, 2006 Jan.
Artigo em Francês | MEDLINE | ID: mdl-16446626

RESUMO

INTRODUCTION: Progressive multifocal leukoencephalopathy (PML) caused by JC virus (JCV) mostly occurs in different conditions of impaired cellular immunity like acquired immunodeficiency syndrome (AIDS) and rarely when humoral immunity is involved. PML remains unusual although there is a high prevalence of JCV among the population and immunosuppression is not rare because of chemotherapies. METHODS: We present two groups of patients: first, we studied reports of three patients suffering from lymphoma type B who developed a PML, proved by cerebral biopsy. The second group included six HIV-infected patients who developed a PML. No biopsy was made but MRI and the physical examination suggested strong arguments for the diagnosis. RESULTS: In the first group, PML was furthered by humoral immunosuppression (rate of immunoglobulin G under 4 g/l). Average survival was five months. In the second group, HIV-infected patients had a survival range from 2 to 58 months after the first PML symptoms and one of them is still alive. CONCLUSION: Humoral immunosuppression in lymphoma can contribute to the development of PML. PML prognosis is often severe but prolonged survivals were described. So it is necessary to restore a sufficient immunity level. But immunity failure may be insufficient to lead to PML. In the case of lymphomas, the role of malignant lymphocytes in multiplication and mutation of JCV might be an interesting pathophysiological hypothesis.


Assuntos
Leucoencefalopatia Multifocal Progressiva/etiologia , Adulto , Agamaglobulinemia/etiologia , Idoso , Contagem de Linfócito CD4 , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Feminino , Infecções por HIV/complicações , Infecções por HIV/imunologia , Humanos , Hospedeiro Imunocomprometido , Vírus JC/fisiologia , Leucemia Linfocítica Crônica de Células B/complicações , Leucemia Linfocítica Crônica de Células B/imunologia , Leucoencefalopatia Multifocal Progressiva/mortalidade , Leucoencefalopatia Multifocal Progressiva/virologia , Linfoma de Células B/complicações , Linfoma de Células B/imunologia , Masculino , Pessoa de Meia-Idade , Prognóstico , Análise de Sobrevida , Ativação Viral/imunologia
4.
Neurology ; 62(6): 974-7, 2004 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-15037704

RESUMO

Aphasia is usually considered to be rare in multiple sclerosis (MS). To determine the clinical and radiologic characteristics of MS patients with acute aphasia, the authors investigated data from 2,700 patients from three MS centers and found 22 patients with acute aphasia (0.81%). Aphasia was the first clinical manifestation of MS in eight patients (36%). Brain MRI showed giant plaques in eight cases (40%). A full recovery was observed in 14 patients (64%). Furthermore, acute aphasia did not appear to be a criterion for poor prognosis.


Assuntos
Afasia/diagnóstico , Afasia/epidemiologia , Esclerose Múltipla Crônica Progressiva/epidemiologia , Esclerose Múltipla Recidivante-Remitente/epidemiologia , Doença Aguda , Adulto , Anti-Inflamatórios/uso terapêutico , Afasia/tratamento farmacológico , Azatioprina/uso terapêutico , Encéfalo/patologia , Estudos de Coortes , Comorbidade , Progressão da Doença , Feminino , França/epidemiologia , Humanos , Fatores Imunológicos/uso terapêutico , Imunossupressores/uso terapêutico , Interferon beta/uso terapêutico , Imageamento por Ressonância Magnética , Masculino , Metilprednisolona/uso terapêutico , Esclerose Múltipla Crônica Progressiva/tratamento farmacológico , Esclerose Múltipla Recidivante-Remitente/tratamento farmacológico , Prevalência , Recuperação de Função Fisiológica
5.
Rev Neurol (Paris) ; 156(10): 839-47, 2000 Oct.
Artigo em Francês | MEDLINE | ID: mdl-11033512

RESUMO

While outpatient management for chronic neurological diseases is well-established, the impact of inpatient neurological examination in emergency room and university hospital remain largely underestimated. We prospectively studied the role of the neurologist in patient management, in a primary care university hospital. Over a period of 12 months, we prospectively recorded the demographics of patients requiring examination in the emergency room, the initial suspected neurological diagnosis of the emergency room, the final diagnosis of the neurology team, and the patients' outcomes. For each patient, the time between admission, the call and the neurological examination were recorded. Neurological examinations were performed in 2220 patients in whom 75.6 p.100 were performed in the emergency room. These latter patients corresponded to 14 p.100 of all patients admitted in the emergency room. Of examined patients, 52 p.100 were male and mean age was 56.9 +/- 21 years. The time between admission and examination was 32 min. (+/- 36 min), irrespective of the day of the week, and depended on the suspected diagnosis: shorter in stroke and status epilepticus (p<0.05), and longer in loss of consciousness and vertigo (p<0.01). Forty-four percent of the examinations took place in the evening and night. The reasons for examinations were: stroke (28.3 p.100), epilepsy (17.7 p.100), headaches (8.4 p.100), loss of consciousness (7.9 p.100), cognitive dysfunctions (4.1 p.100), neuropathies (4 p.100) and miscellaneous (8.1 p.100). Neurological examinations modified neurological diagnosis and treatment in more than 86 p.100 of the patients. Following neurological examination, 17.2 p.100 of the patients were able to go home, while the rest were admitted to the stroke unit (27.2 p.100), the general neurological unit (27.3 p.100) or in other departments (28.3 p.100), of which intensive care unit (5.3 p.100) or neurosurgery (5.9 p.100). Emergency neurologic examination improves neurological diagnosis and has a positive impact both on treatment and, more globally, in patient management.


Assuntos
Emergências , Pacientes Internados , Exame Neurológico , Consultores , Serviço Hospitalar de Emergência/estatística & dados numéricos , Reações Falso-Negativas , Reações Falso-Positivas , Feminino , França , Hospitais Universitários/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais , Estado Epiléptico/diagnóstico , Estado Epiléptico/epidemiologia , Acidente Vascular Cerebral/diagnóstico , Acidente Vascular Cerebral/epidemiologia , Inconsciência/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...